Volume 82, Issue 5, 1 March 2025

Marstacimab-hncq

• Extract
• View article

Inavolisib

• Extract
• View article

Oral history collection gives personal look at public health pharmacy

• Extract
• View article

Summaries of safety labeling changes approved by FDA—Boxed warnings highlights, October–December 2024

• Extract
• View article

Implementing a risk stratification protocol for patients with migraine in a health-system specialty pharmacy setting

• Extract
• View article

Clinical review of substitutions or alternatives for critical chemotherapy drug shortages in hematologic malignancies

• Abstract
• View article

Neuromuscular monitoring: A tutorial for pharmacists

• Abstract
• View article

Severe hypersensitivity reactions to 2 immunotherapy agents in a patient with cutaneous squamous cell carcinoma

• Abstract
• View article

Dual prostacyclin infusions: A case report of a patient symptom–driven transition from high-dose intravenous epoprostenol to subcutaneous treprostinil for the treatment of pulmonary arterial hypertension

• Abstract
• View article

An international, multicenter post hoc analysis comparing in-person and virtual medication management strategies in post-ICU recovery clinics

• Abstract
• View article
• Supplementary data

Physicochemical and microbiological stability of 40 mg/mL amiodarone hydrochloride oral suspension

• Abstract
• View article
• Supplementary data

Implementation of HLA-related genotype-guided prescribing in Singapore

• Abstract
• View article

Evaluation and redesign of an internal medicine pharmacy practice model at a tertiary care hospital

• Abstract
• View article
• Supplementary data

Experience of a peer prereview service including a junior reviewer program in a professional association

• Abstract
• View article
• Supplementary data

Development and implementation of autoverification standardization in the adult and pediatric emergency department

• Abstract
• View article